References
- Caldon CE, Sergio CM, Burgess A, Deans AJ, Sutherland RL, Musgrove EA. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1. Cell Cycle 2013; 12; PMID: 23324395
- Caldon CE, Sergio CM, Sutherland RL, Musgrove EA. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells. Cell Cycle 2013; 12; PMID: 23324394
- Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, et al. Kinase-independent function of cyclin E. Mol Cell 2007; 25:127 - 39; http://dx.doi.org/10.1016/j.molcel.2006.11.029; PMID: 17218276
- Matsumoto Y, Maller JL. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 2004; 306:885 - 8; http://dx.doi.org/10.1126/science.1103544; PMID: 15514162
- Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, et al. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 1998; 17:2637 - 43; http://dx.doi.org/10.1038/sj.onc.1202477; PMID: 9840927
- Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24:2776 - 86; http://dx.doi.org/10.1038/sj.onc.1208613; PMID: 15838514
- Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431 - 43; http://dx.doi.org/10.1016/S0092-8674(03)00645-7; PMID: 12941272
- Nevzorova YA, Tschaharganeh D, Gassler N, Geng Y, Weiskirchen R, Sicinski P, et al. Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology 2009; 137:691 - 703, 703, e1-6; http://dx.doi.org/10.1053/j.gastro.2009.05.003; PMID: 19445941
- Caldon CE, Musgrove EA. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 2010; 5:2; http://dx.doi.org/10.1186/1747-1028-5-2; PMID: 20180967